Non-insulin oral drug(s)-Glucotrol (Glipizide) Posts on Medivizor
Navigation Menu

Non-insulin oral drug(s)-Glucotrol (Glipizide) Posts on Medivizor

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Can combined therapy with sodium-glucose co-transporter 2 inhibitors and sulfonylureas affect the risk of hypoglycemia in patients with type 2 diabetes?

Posted by on Dec 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review assessed the risk of hypoglycemia (dangerously low blood glucose) with the addition of sodium-glucose co-transporter 2 (SGLT-2) inhibitors to sulfonylureas in patients with type 2 diabetes (T2D). The authors concluded that this combination was associated with an increased risk of hypoglycemia. Some background...

Read More

Looking for patients with type 2 diabetes to test a new treatment tirzepatide

Posted by on Feb 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is examining the effectiveness of tirzepatide compared to insulin glargine in patients with type 2 diabetes who are also at high risk for heart disease. The main outcome to be measured will be a change in HbA1c (a blood test that measures average blood sugar levels in the past 3 months) over 52 weeks. The details In type 2...

Read More

Treating diabetes: Which drug is safer?

Posted by on Oct 6, 2014 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risks associated with treatment with a sulphonylurea or metformin (Glucophage) in patients with type 2 diabetes. Some background Type 2 diabetes is a chronic, progressive disease that occurs due to increased resistance to insulin. It can be treated with several drugs. The first-line drug, which is most...

Read More

A comparison between the effects of Sulfonylurea and Metformin on cardiovascular events in patients with type 2 Diabetes Mellitus

A comparison between the effects of Sulfonylurea and Metformin on cardiovascular events in patients with type 2 Diabetes Mellitus

Posted by on Feb 23, 2013 in Diabetes mellitus | 1 comment

In a nutshell The present study compared the effects of therapy with either Metformin or Sulfonylureas (Glyburide, Glipizide) on cardiovascular events (heart attack and stroke) or death in patients with type 2 diabetes mellitus (DM2). The main findings were that treatment with Sulfonylurea was associated with an increased risk of cardiovascular disease...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor